January 11, 2021

Global Hematopoietic Stem Cell Transplantation Market 2020 Precise Scenario Covering Trends, Opportunities and Growth Forecast 2025

A collective analysis report titled Global Hematopoietic Stem Cell Transplantation (HSCT) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 analyzes the market status and outlook from the

Organ Transplant Technology

Tech & Industry

World

January 6, 2021

FRANCE: CARMAT Outlines Commercial and Development Plan for Its Total Artificial Heart

CARMAT (Paris: ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to

Intestinal Transplants

Organ Transplant Technology

Pediatric Transplant

Stem Cell Transplants

Tech & Industry

Tissue Transplants

January 6, 2021

At UPMC, Android-enabled telehealth keeps child transplant patients safe

The UPMC Children's Hospital of Pittsburgh was the nation's first center to perform organ transplantation in children. It has performed more solid organ transplants in children than any U.S. center. With

Organ Transplant Technology

Tech & Industry

January 1, 2021

Telehealth Helps MUSC Improve Kidney Transplant Screening Process

By Eric Wicklund December 31, 2020 - A telehealth platform has helped the Medical University of South Carolina screen patients for kidney transplants during the coronavirus pandemic – in some cases

by Transplant News

Bone Marrow Transplants

Business

Organ Transplant Technology

Tech & Industry

December 20, 2020

Impact of COVID-19 on Bone Marrow Transplant Rejection Treatment Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026

Bone Marrow Transplant Rejection Treatment, Bone Marrow Transplant Rejection Treatment market Bone Marrow Transplant Rejection Treatment Market research report is the new statistical data source added by A2Z Market Research. “Bone Marrow Transplant Rejection

Organ Transplant Technology

Pediatric Transplant

Tech & Industry

December 18, 2020

FDA Approves Labeling Update for Abbott’s HeartMate 3 Heart Pump for use in Pediatric Patients

ABBOTT PARK, Ill., Dec. 17, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved updated labeling for the company's HeartMate 3™ heart pump

Organ Transplant Technology

Organ Transplant Transport

Tech & Industry

December 12, 2020

Organ Transplantation Market Size to Witness Healthy CAGR Growth of 6.50% by 2024

Selbyville, Delaware Market Study Report, has recently added a report on the Organ Transplantation market' which presents substantial inputs about the market size, market share, regional trends, and profit projection

by Transplant News

Business

Innovation

Organ Transplant Technology

Pediatric Transplant

Tech & Industry

December 5, 2020

Paragonix Technologies, Inc., Announces First Successful Use of Paragonix SherpaPak™ Cardiac Transport System in Pediatric Transplant Recipients

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. today announced that the first series of pediatric donor hearts preserved and transported using Paragonix SherpaPak Cardiac Transport System occurred at University of Florida Health

by Transplant News

Bone Marrow Transplants

Business

Hospitals

Innovation

Organ Transplant Technology

Tech & Industry

World

December 3, 2020

Global Bone Marrow Transplant Rejection Treatment Market Analysis, Company Profile, Future Estimations by 2027 – The Courier

Bone Marrow Transplant Rejection Treatment Market The Bone Marrow Transplant Rejection Treatment market report, published by Syndicate Market Research, offers an organized assessment of the important aspects of the global Bone Marrow Transplant

by Transplant News

Business

Innovation

Organ Transplant Technology

Stem Cell Transplants

Tech & Industry

December 3, 2020

Therapy Response Predicts Stem Cell Transplant Survival in AL Amyloidosis

In light-chain (AL) amyloidosis, a rare plasma cell disease marked by excess deposit of protein in the organs, the goal of therapy is to inhibit the production of amyloidogenic light

by Transplant News

LOAD MORE STORIES